Asthma Deck 2

Question 1

Step 3 and 4 – 4 year olds with persistent

asthma – follow

Answer 1

step 3 and 4 (5-11 y.o.)
– Daily and PRN combination low-dose ICSformoterol
or daily and PRN combination
medium-dose ICS-formoterol

Question 2

Steps 2–4: for 5 to 11 note

Answer 2

Conditionally recommend the use of subcutaneous immunotherapy as an adjunct treatment to standard pharmacotherapy in individuals ≥ 5 years of age whose asthma is controlled at the initiation, build up, and maintenance phases of immunotherapy

Question 3

SMART Therapy

Answer 3

ICS-formoterol – single maintenance and
reliever therapy used both daily and as
needed

Question 4

12+ step two notes

Answer 4

mild persistent asthma, either of the
following two treatments are recommended
as part of Step 2 therapy: 1) a daily low-dose
ICS and as-needed SABA for quick-relief
therapy,

Question 5

12+ step 2 - 4 notes

Answer 5

SCIT – evidence of worsening

allergies after exposure

Question 6

12+ step 3 and 4 notes

Answer 6

moderate to severe
persistent asthma taking low or medium dose
ICS, preferred treatment – SMART therapy

Question 7

Asthma Control

Answer 7

Well-controlled, not-well controlled and very
poorly controlled.
• In patients already taking controller asthma
therapy
• Medication is adjusted according to asthma
control
• Therapy should be reassessed at each visit
• Asthma is a variable condition
• The management of asthma changes with the
patient’s needs over time.
• Stepwise approach to management

Question 8

Important to reduce exposure

Answer 8

to allergens

and triggers

Question 9

sources of allergens

Answer 9

house dust mites, pets, cockroaches, mold

Question 10

factors that can exaerbate asthma

Answer 10

tobacco smoke, wood smoke, household sprays

Question 11

goals of acute exacerbation

Answer 11

Relieve airway obstruction and hypoxemia, and

normalize lung function as quickly as possible

Question 12

initial therapy for acute asthma exacerbation

Answer 12

– Oxygen—To relieve hypoxemia
– A systemic glucocorticoid—To reduce airway inflammation
– A nebulized, high-dose SABA—To relieve airflow obstruction
– Nebulized ipratropium—To further reduce airflow obstruction

Question 13

Excercise induced cause

Answer 13

bronchospasm secondary to loss of heat and/or

water from the lung

Question 14

exercise induced startes

Answer 14

either during or immediately after exercise, peaks

in 5 to 10 minutes, and resolves 20 to 30 minutes later

Question 15

exercise induced treatment

Answer 15

SABA or cromolyn administered prophylactically
– Inhaled SABAs generally preferred over cromolyn

• Beta2 agonists should be inhaled immediately before
exercise

• Cromolyn should be inhaled 15 minutes before exercise

Question 16

All people with asthma should have

Answer 16

a written asthma action plan to guide their self-managment eforts

Question 17

Follow up, how often and what do you do

Answer 17

• Follow-up in 1 to 2 weeks
• Monthly
• Asthma Control Test
• Consider step-down, when possible

Question 18

GINA no longer

Answer 18

recommends treatemnt with a SABA alone

Question 19

GINA recomeneds

Answer 19

ICS to reduce risk of sercious excerbations

Question 20

GINA recomends what for mild asthma

Answer 20

For mild asthma, as-needed low-dose ICS
and low-dose formoterol are recommended
(USA black box warning).

Question 21

If formoterol is not available, the patient should

take l

Answer 21

low-dose ICS whenever SABA is taken

Question 22

GINA mild asthma/well controlled recomendations

Answer 22

Well-controlled with as-needed
reliever medication alone or with low-intensity
controller treatment such as low-dose inhaled
corticosteroids (ICSs), leukotriene receptor
antagonists, or chromones

Question 23

GINA moderate asthama recomendations

Answer 23

Well-controlled with lowdose

ICS/long-acting beta2-agonists (LABA)

Question 24

GINAL severe asthma recomendations

Answer 24

Requires high-dose
ICS/LABA to prevent it from becoming
uncontrolled, or asthma that remains
uncontrolled despite this treatment